NO960684D0 - Monoklonalt antistoff som induserer apoptose - Google Patents

Monoklonalt antistoff som induserer apoptose

Info

Publication number
NO960684D0
NO960684D0 NO960684A NO960684A NO960684D0 NO 960684 D0 NO960684 D0 NO 960684D0 NO 960684 A NO960684 A NO 960684A NO 960684 A NO960684 A NO 960684A NO 960684 D0 NO960684 D0 NO 960684D0
Authority
NO
Norway
Prior art keywords
antibody
monoclonal antibody
induces apoptosis
myelocytic
cell
Prior art date
Application number
NO960684A
Other languages
English (en)
Other versions
NO960684L (no
Inventor
Naoshi Fukushima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO960684D0 publication Critical patent/NO960684D0/no
Publication of NO960684L publication Critical patent/NO960684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO960684A 1993-09-03 1996-02-21 Monoklonalt antistoff som induserer apoptose NO960684L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP05242110 1993-09-03
PCT/JP1994/001453 WO1995006748A1 (fr) 1993-09-03 1994-09-02 Anticorps monoclonal permettant d'induire une apoptose

Publications (2)

Publication Number Publication Date
NO960684D0 true NO960684D0 (no) 1996-02-21
NO960684L NO960684L (no) 1996-02-21

Family

ID=17084452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960684A NO960684L (no) 1993-09-03 1996-02-21 Monoklonalt antistoff som induserer apoptose

Country Status (19)

Country Link
US (4) US5840344A (no)
EP (1) EP0721015B1 (no)
KR (1) KR100241863B1 (no)
CN (1) CN1046314C (no)
AT (1) ATE280835T1 (no)
AU (1) AU692466B2 (no)
CA (1) CA2169950A1 (no)
CZ (1) CZ294359B6 (no)
DE (1) DE69434097T2 (no)
FI (1) FI960567A (no)
HU (1) HU222989B1 (no)
NO (1) NO960684L (no)
PL (1) PL181783B1 (no)
RU (1) RU2202615C2 (no)
SK (1) SK281964B6 (no)
TW (1) TW426687B (no)
UA (1) UA50708C2 (no)
WO (1) WO1995006748A1 (no)
ZA (1) ZA946767B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280835T1 (de) * 1993-09-03 2004-11-15 Chugai Pharmaceutical Co Ltd Apoptose induzierender monoklonaler antikörper
EP0903149A4 (en) * 1996-03-06 2002-02-13 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING SUBSTANCES INDUCING APOPTOSIS
AU733322B2 (en) 1996-07-15 2001-05-10 Chugai Seiyaku Kabushiki Kaisha Novel VEGF-like factor
US7531643B2 (en) * 1997-09-11 2009-05-12 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
PL339265A1 (en) * 1997-09-11 2000-12-04 Chugai Pharmaceutical Co Ltd Apoptose causing monoclonal antibody
EP1167388A4 (en) * 1999-03-10 2002-05-29 Chugai Pharmaceutical Co Ltd APOPTOSE INDUCING SINGLE STRING FV
US7696325B2 (en) 1999-03-10 2010-04-13 Chugai Seiyaku Kabushiki Kaisha Polypeptide inducing apoptosis
US20040058393A1 (en) * 2000-04-17 2004-03-25 Naoshi Fukishima Agonist antibodies
KR20030055274A (ko) 2000-10-20 2003-07-02 츄가이 세이야꾸 가부시키가이샤 저분자화 트롬보포에틴 아고니스트 항체
JP4261907B2 (ja) * 2000-10-20 2009-05-13 中外製薬株式会社 低分子化アゴニスト抗体
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
WO2003044482A2 (en) * 2001-11-16 2003-05-30 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells
EP1561759B9 (en) 2002-10-11 2009-08-26 Chugai Seiyaku Kabushiki Kaisha Cell death-inducing agent
JP2004279086A (ja) * 2003-03-13 2004-10-07 Konica Minolta Holdings Inc 放射線画像変換パネル及び放射線画像変換パネルの製造方法
WO2004087763A1 (ja) * 2003-03-31 2004-10-14 Chugai Seiyaku Kabushiki Kaisha Ｃｄ２２に対する改変抗体およびその利用
TW200530269A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
EP1712565A4 (en) * 2003-12-12 2009-03-11 Chugai Pharmaceutical Co Ltd AGENTS INDUCING CELL DEATH
TW200530266A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Method of reinforcing antibody activity
WO2005056602A1 (ja) * 2003-12-12 2005-06-23 Chugai Seiyaku Kabushiki Kaisha アゴニスト活性を有する改変抗体のスクリーニング方法
WO2006106903A1 (ja) 2005-03-31 2006-10-12 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2構造異性体
EP1927367A4 (en) * 2005-05-18 2009-08-12 Univ Tokushima NOVEL PHARMACEUTICAL AGENT BASED ON AN ANTI-HLA ANTIBODY
US9241994B2 (en) 2005-06-10 2016-01-26 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical compositions containing sc(Fv)2
KR101367544B1 (ko) 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
WO2007100892A2 (en) * 2006-02-28 2007-09-07 The Board Of Trustees Of The Leland Stanford Junior University Trojan horse immunotherapy
CA2657385A1 (en) * 2006-07-13 2008-01-17 Naoki Kimura Cell death inducer
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
WO2016090337A1 (en) 2014-12-05 2016-06-09 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
BR112018011336A2 (pt) 2015-12-04 2018-12-04 Memorial Sloan-Kettering Cancer Center anticorpo anti-fcrl5 isolado ou um fragmento de ligação ao antígeno do mesmo, anticorpo scfv anti-fcrl5 isolado, anticorpo isolado ou porção de ligação ao antígeno do mesmo, composição, imunoconjugado, molécula biespecífica, ácido nucleico isolado, vetor de expressão, célula hospedeira, método para detectar fcrl5 em uma célula ou tecido inteiro, método para tratar câncer em um indivíduo, uso do anticorpo ou fragmento de ligação ao antígeno do mesmo, kit para tratar câncer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280835T1 (de) * 1993-09-03 2004-11-15 Chugai Pharmaceutical Co Ltd Apoptose induzierender monoklonaler antikörper
EP0903149A4 (en) * 1996-03-06 2002-02-13 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING SUBSTANCES INDUCING APOPTOSIS
PL339265A1 (en) * 1997-09-11 2000-12-04 Chugai Pharmaceutical Co Ltd Apoptose causing monoclonal antibody
EP1167388A4 (en) * 1999-03-10 2002-05-29 Chugai Pharmaceutical Co Ltd APOPTOSE INDUCING SINGLE STRING FV

Also Published As

Publication number Publication date
DE69434097D1 (de) 2004-12-02
KR100241863B1 (ko) 2000-03-02
DE69434097T2 (de) 2006-02-02
SK25596A3 (en) 1996-10-02
CZ294359B6 (cs) 2004-12-15
US20030147894A1 (en) 2003-08-07
UA50708C2 (uk) 2002-11-15
FI960567A0 (fi) 1996-02-07
AU7546694A (en) 1995-03-22
CN1130405A (zh) 1996-09-04
WO1995006748A1 (fr) 1995-03-09
HUT74594A (en) 1997-01-28
AU692466B2 (en) 1998-06-11
CN1046314C (zh) 1999-11-10
PL181783B1 (pl) 2001-09-28
US6267959B1 (en) 2001-07-31
HU9600206D0 (en) 1996-03-28
CZ61796A3 (en) 1996-06-12
US20010001712A1 (en) 2001-05-24
HU222989B1 (hu) 2004-01-28
EP0721015A4 (en) 1999-03-31
RU2202615C2 (ru) 2003-04-20
EP0721015B1 (en) 2004-10-27
SK281964B6 (sk) 2001-09-11
TW426687B (en) 2001-03-21
US6759043B2 (en) 2004-07-06
US5840344A (en) 1998-11-24
PL313260A1 (en) 1996-06-24
ZA946767B (en) 1995-04-03
EP0721015A1 (en) 1996-07-10
FI960567A (fi) 1996-02-07
NO960684L (no) 1996-02-21
CA2169950A1 (en) 1995-03-09
ATE280835T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
NO960684D0 (no) Monoklonalt antistoff som induserer apoptose
NO2017040I1 (no) Natalizumab, anti alfa-4 integrin humanisert monoklonalt antistoff - forlenget SPC
DE69321218D1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
NO20001238D0 (no) Monoklonalt antistoff som induserer apoptose
NO944247D0 (no) Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE3586216T2 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DK0840620T3 (da) IL-8-antagonister til behandling af astma
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
ATE318844T1 (de) Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
NO894555L (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
IT1254315B (it) Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
ATE58173T1 (de) Monoklonale antikoerper und immunisierung damit.
NO960683D0 (no) Monoklonalt antistoff som gjenkjenner interstitialcelle-overflateantigen
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application